Imlunestrant, an Oral Selective Estrogen Receptor Degrader, as Monotherapy and in Combination With Targeted Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Phase Ia/Ib EMBER Study
伊姆伦司群（一种口服选择性雌激素受体降解剂）单药治疗及联合靶向治疗在雌激素受体阳性、人表皮生长因子受体2阴性晚期乳腺癌中的疗效：EMBER Ia/Ib期研究
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.23.02733
Jhaveri, Komal L; Lim, Elgene; Jeselsohn, Rinath; Ma, Cynthia X; Hamilton, Erika P; Osborne, Cynthia; Bhave, Manali; Kaufman, Peter A; Beck, J Thaddeus; Manso Sanchez, Luis; Parajuli, Ritesh; Wang, Hwei-Chung; Tao, Jessica J; Im, Seock-Ah; Harnden, Kathleen; Yonemori, Kan; Dhakal, Ajay; Neven, Patrick; Aftimos, Philippe; Pierga, Jean-Yves; Lu, Yen-Shen; Larson, Timothy; Jerez, Yolanda; Sideras, Kostandinos; Sohn, Joohyuk; Kim, Sung-Bae; Saura, Cristina; Bardia, Aditya; Sammons, Sarah L; Bacchion, Francesca; Li, Yujia; Yuen, Eunice; Estrem, Shawn T; Rodrik-Outmezguine, Vanessa; Nguyen, Bastien; Ismail-Khan, Roohi; Smyth, Lillian; Beeram, Muralidhar
